FDA Orange Book · active-ingredient family
Estazolam
Estazolam is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:PROSOM · NDA 019080
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PROSOMRLD×2 | ABBOTT | NDA 019080 | — | Dec 26, 1990 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ESTAZOLAM×2 | WATSON LABS | ANDA 074818 | AB | Aug 19, 1997 | |
| ESTAZOLAM×2 | DR REDDYS LABS SA | ANDA 074921 | AB | Jul 10, 1997 | |
| ESTAZOLAM×2 | NOVITIUM PHARMA | ANDA 074826 | AB | Jul 03, 1997 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Estazolam — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

